Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, MicroRNA in disease regulation, and Cancer-related molecular mechanisms research.
Integrated multi-omics reveals glycolytic gene signatures of lung adenocarcinoma brain metastasis and the impact of Rac2 lactylation on immunosuppressive microenvironment
Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration
Expert Consensus on the Diagnosis and Treatment of Malignant Mesothelioma of the Tunica Vaginalis Testis
The Potential Mechanisms Involved in the Disruption of Spermatogenesis in Mice by Nanoplastics and Microplastics
Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid Tumors
Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid Tumors
PFKP silencing suppresses tumor growth via the AXL-MET axis
PD-1/PD-L1 Inhibitors Plus Antiangiogenic Drugs Versus Sorafenib as the First Line Treatment for Advanced Hepatocellular Carcinoma: A Phase 3 RCTs Based Meta-Analysis
Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma
Intrathecal chemotherapy combined with systemic therapy in patients with refractory leptomeningeal metastasis of non-small cell lung cancer: a retrospective study
Expert consensus on the diagnosis and treatment of <scp>RET</scp> gene fusion <scp>non‐small</scp> cell lung cancer in <scp>China</scp>
A hepatocyte-targeting nanoparticle for enhanced hepatobiliary magnetic resonance imaging
A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma
Potential benefit of osimertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer
Efficacy and safety of KL-A167 in previously treated recurrent or metastatic nasopharyngeal carcinoma: a multicenter, single-arm, phase 2 study
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
Chinese expert consensus on the diagnosis and treatment of <scp>HER2</scp>‐altered non–small cell lung cancer
Expert consensus on the diagnosis and treatment of <scp><i>NTRK</i></scp> gene fusion solid tumors in China
Acetylation of Atp5f1c Mediates Cardiomyocyte Senescence via Metabolic Dysfunction in Radiation‐Induced Heart Damage
Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients
FGFR2-ERC1: A Subtype of FGFR2 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Anlotinib
Efficacy and Safety of KL-A167 in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter, Single-Arm, Phase 2 Study
Efficacy of Concurrent Chemoradiotherapy With S-1 vs Radiotherapy Alone for Older Patients With Esophageal Cancer
Structure–Relaxivity Mechanism of an Ultrasmall Ferrite Nanoparticle T<sub>1</sub> MR Contrast Agent: The Impact of Dopants Controlled Crystalline Core and Surface Disordered Shell
Radiation‑induced dysfunction of energy metabolism in the heart results in the fibrosis of cardiac tissues
Effect and safety of anlotinib combined with S-1 for recurrent or metastatic esophageal cancer patients who refused or were intolerant to intravenous chemotherapy
A Novel KIF5B-EGFR Fusion Variant in Non-Small-Cell Lung Cancer and Response to Afatinib: A Case Report
Efficacy and acquired resistance for EGFR-TKI plus thoracic SBRT in patients with advanced EGFR-mutant non–small-cell lung cancer: a propensity-matched retrospective study